A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

Clinical trial NCT07570173 · RECRUITING

Trial details

NCT number: NCT07570173
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2026-05-18
Primary completion: 2033-10-18
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.